Joan B. Heijns

2.3k citations

33 papers · 364 indexed · h-index 11

Cancer Research
- Breast Cancer Treatment Studies 17
- Cancer Genomics and Diagnostics 4
Oncology
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 8
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 11
Pathology and Forensic Medicine
- Breast Lesions and Carcinomas 2
Genetics
Radiology, Nuclear Medicine and Imaging
- Medical Imaging Techniques and Applications 3
- Radiopharmaceutical Chemistry and Applications 2

Co-authors: Hanneke W.M. van Laarhoven Saskia van de Ven Vincent T.H.B.M. Smit Lonneke W. Kessels Judith R. Kroep Ernest J. T. Luiten Birgit E. P. J. Vriens Jolien Tol
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: Breast Cancer Research and Treatment (7 papers)Journal of Clinical Oncology (5 papers)ESMO Open (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Joan B. Heijns

30 papers receiving 361 citations

Peers

Countries citing papers authored by Joan B. Heijns

Since Specialization

Citations

This map shows the geographic impact of Joan B. Heijns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan B. Heijns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan B. Heijns more than expected).

Fields of papers citing papers by Joan B. Heijns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan B. Heijns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan B. Heijns. The network helps show where Joan B. Heijns may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Joan B. Heijns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joan B. Heijns Line = papers co-authored together Joan B. Heijns links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Complete responders in patients with HER2-positive metastatic breast cancer: a real-world SONABRE study The Breast ·修三堤,José Pablo Aguiar Moya,Sandra M. E. Geurts,Jolien Tol,Birgit E. P. J. Vriens,William Fawley,Eline Boon,M. Wouter Dercksen,Franchette van den Berkmortel,Manon J. Pepels,Natascha A. J. B. Peters,Joan B. Heijns,優一大森,Don Lambert,Vivianne C. G. Tjan‐Heijnen,Maaike de Boer	2025	0
2	Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial EClinicalMedicine ·Hugo Alberto Cervantes Flores,Ron H.J. Mathijssen,Maaike de Boer,Johanna Luise Mayer,Joan B. Heijns,Birgit E. P. J. Vriens,Ana M. F. Ventura,Lonneke W. Kessels,Raymond Dean Chase,Karin Beelen,Peter Nieboer,Susan M. van den Berg,Esther Oomen‐de Hoop,Rhodé M. Bijlsma,Monique E.M.M. Bos	2025	1
3	202P Complete response rates, treatment patterns and survival outcomes in patients treated with first-line pertuzumab-based therapy in HER2-positive advanced breast cancer: A SONABRE study ESMO Open ·Mariam Siddique,Sandra M. E. Geurts,J. Tol,Birgit E. P. J. Vriens,William Fawley,Eline Boon,M. W. Dercksen,F. Van den Berkmortel,Manon J. Pepels,Natascha A. J. B. Peters,Joan B. Heijns,優一大森,K. E. Sherman,V.C.G. Tjan-Heijnen,Maaike de Boer	2024	1
4	The prognostic impact of BMI in patients with HR+/HER2− advanced breast cancer: a study of the SONABRE registry Breast Cancer Research and Treatment ·A. Zijlmans,Р С Игембаева,Ingeborg J. H. Vriens,Adam Cassis,Sanne Engelen,Frans Erdkamp,M. Wouter Dercksen,Birgit E. P. J. Vriens,William Fawley,Manon J. Pepels,Maidan Fahmi,Natascha A. J. B. Peters,Jolien Tol,Joan B. Heijns,Agnès J. van de Wouw,Bakary Coulibaly,Sandra M. E. Geurts,Vivianne C. G. Tjan‐Heijnen	2023	4
5	Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry The Lancet Regional Health - Europe ·Adam Cassis,Sandra M. E. Geurts,Frans Erdkamp,M. Wouter Dercksen,Birgit E. P. J. Vriens,William Fawley,Manon J. Pepels,Maidan Fahmi,Natascha A. J. B. Peters,Jolien Tol,Joan B. Heijns,Agnès J. van de Wouw,Earl G. Lee,Hirohito SUZUKI,Vivianne C. G. Tjan‐Heijnen	2023	15
6	Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival npj Breast Cancer ·Dunia Y. Trujillo,Vanja de Weerd,Mai N. Van,Jaco Kraan,Marcel Smid,Joan B. Heijns,Jan C. Drooger,Johanna M. Zuetenhorst,Peter Krapp,Agnes Jager,Stefan Sleijfer,John W.M. Martens,Saskia M. Wilting	2023	6
7	Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry Clinical Breast Cancer ·Claude Lafleur,Sandra M. E. Geurts,Anna K. McVittie,Adam Cassis,Frans Erdkamp,Joan B. Heijns,Jolien Tol,Birgit E. P. J. Vriens,William Fawley,M. Wouter Dercksen,Manon J. Pepels,Natascha A. J. B. Peters,Maidan Fahmi,Agnès J. van de Wouw,Don Lambert,Hirohito SUZUKI,Vivianne C. G. Tjan‐Heijnen	2023	1
8	Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry Breast Cancer Research and Treatment ·Claude Lafleur,Sandra M. E. Geurts,Adam Cassis,Frans Erdkamp,Joan B. Heijns,Jolien Tol,Birgit E. P. J. Vriens,M. Wouter Dercksen,William Fawley,Manon J. Pepels,優一大森,Natascha A. J. B. Peters,Chen Xiao-kun,Ingeborg J. H. Vriens,Vivianne C. G. Tjan‐Heijnen	2023	7
9	233P Treatment pattern and outcomes for the first two lines of chemotherapy in patients diagnosed with metastatic triple-negative breast cancer, results from the Dutch SONABRE Registry ESMO Open ·Sandra M. E. Geurts,Mariam Siddique,Adam Cassis,Frans Erdkamp,Joan B. Heijns,J. Tol,Birgit E. P. J. Vriens,P. Y. Gorter,William Fawley,Manon J. Pepels,優一大森,Natascha A. J. B. Peters,A. van de Wouw,Bakary Coulibaly,Maaike de Boer,Vivianne C. G. Tjan‐Heijnen	2023	1
10	Abstract P3-07-07: The use of ribociclib/letrozole combination as an alternative for neoadjuvant chemotherapy in selected patients with early luminal breast cancer Cancer Research ·Cheryl Yin,Daniëlle Cohen,Joan B. Heijns,Caroline M.P.W. Mandigers,張生平,Hein Putter,Elma Meershoek‐Klein Kranenbarg,Marjolijn Duijm‐de Carpentier,昭哉渡我部,Elise van Leeuwen-Stok,Gerrit‐Jan Liefers,Sabine C. Linn,Judith R. Kroep	2023	1
11	Quantification of ribociclib in dried blood spots by LC–MS/MS: Method development and clinical validation Journal of Pharmaceutical and Biomedical Analysis ·C. Louwrens Braal,Lingxue Yi,Jingjing Xu,Ria Komara Dewi,Terry Williams,Joan B. Heijns,Monique E.M.M. Bos,Ron H.J. Mathijssen,Peter de Bruijn,Stijn L.W. Koolen	2021	12
12	Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study Breast Cancer Research and Treatment ·Janine M. Simons,Christopher James Heiman,香原志勢,B Alkenings,Leandra J M Boonman-de Winter,Arjen M. Rijken,Paul D. Gobardhan,Jan H. Wijsman,Eric Tetteroo,Joan B. Heijns,Larisa Anatol'evna Doroshuk,Ernest J. T. Luiten	2020	28
13	Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer ESMO Open ·Rhodé M. Bijlsma,Aleksandr Sergeevich Kholodov,Hester Wessels,Stefan Sleijfer,Laurens V. Beerepoot,Daan ten Bokkel Huinink,Hester van Cruijsen,Joan B. Heijns,Martijn P. Lolkema,Neeltje Steeghs,Theo van Voorthuizen,Annelie Vulink,Els O. Witteveen,Margreet G.E.M. Ausems,Annelien L. Bredenoord,Anne M. May,Emile E. Voest	2020	12
14	Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01) Breast Cancer Research ·Stefanie de Groot,Hanno Pijl,Ayoub Charehbili,Saskia van de Ven,Vincent T.H.B.M. Smit,Elma Meershoek‐Klein Kranenbarg,Joan B. Heijns,L.J.C. van Warmerdam,Lonneke W. Kessels,M. Wouter Dercksen,Manon J. Pepels,Hanneke W.M. van Laarhoven,Birgit E. P. J. Vriens,Hein Putter,Marta Fiocco,Gerrit‐Jan Liefers,Jacobus J. M. van der Hoeven,J.W.R. Nortier,Judith R. Kroep	2019	7
15	Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy Breast Cancer Research and Treatment ·M. M. G. A. van den Berg,Dieuwertje E. Kok,巌逢坂,G. M. Joshi,Vanessa Berlanga Silvente,Yevgenia Emchenko,Maud M. Geenen,A. Haringhuizen,Joan B. Heijns,Z. Boudaoud,Maartje Los,Dirkje W. Sommeijer,Johanna N.H. Timmer-Bonte,奥田圭,Hanneke W.M. van Laarhoven,Ellen Kampman,Renate M. Winkels	2018	33
16	Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy European Journal of Surgical Oncology ·R Theeuwen,Eric Tetteroo,Ernest J. T. Luiten,Paul D. Gobardhan,H.J.T. Rutten,Joan B. Heijns,Adri C. Voogd,Elisabeth G. Klompenhouwer	2016	8
17	Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01) Breast Cancer Research ·Stefanie de Groot,Mansoor S. Al-Harbi,Hanneke W.M. van Laarhoven,Antien L. Mooyaart,Annevi Kant,Saskia van de Ven,Laura G.M. Janssen,Jesse J. Swen,Vincent T.H.B.M. Smit,Joan B. Heijns,Lonneke W. Kessels,Tahar van der Straaten,Stefan Böhringer,Hans Gelderblom,Jacobus J. M. van der Hoeven,Henk‐Jan Guchelaar,Hanno Pijl,Judith R. Kroep	2016	33
18	Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy Molecular Cancer Therapeutics ·Wendy Onstenk,Jaco Kraan,Bianca Mostert,GINN-PEASE,Ayoub Charehbili,Vincent T.H.B.M. Smit,Judith R. Kroep,J.W.R. Nortier,Saskia van de Ven,Joan B. Heijns,Lonneke W. Kessels,Hanneke W.M. van Laarhoven,Monique M.E.M. Bos,Cornelis J.�H. van de Velde,Jan W. Gratama,Anieta M. Sieuwerts,John W.M. Martens,John A. Foekens,Stefan Sleijfer	2014	47
19	Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01) Annals of Oncology ·Ayoub Charehbili,Saskia van de Ven,Vincent T.H.B.M. Smit,Elma Meershoek‐Klein Kranenbarg,N.A.T. Hamdy,Hein Putter,Joan B. Heijns,L.J.C. van Warmerdam,Lonneke W. Kessels,M. Wouter Dercksen,Manon J. Pepels,E. Maartense,Hanneke W.M. van Laarhoven,Birgit E. P. J. Vriens,Martin N.J.M. Wasser,A. Elise van Leeuwen‐Stok,Gerrit‐Jan Liefers,C.J.H. van de Velde,J. W. R. Nortier,Judith R. Kroep	2014	31
20	Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment Cancer Chemotherapy and Pharmacology ·Joan B. Heijns,Maria E.L. van der Burg,Teun van Gelder,M. W. J. A. Fieren,Peter de Bruijn,Ate van der Gaast,Walter J. Loos	2008	14

About Joan B. Heijns

Joan B. Heijns is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 364 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (17 papers), Advanced Breast Cancer Therapies (11 papers), Cancer Treatment and Pharmacology (10 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Genomics and Diagnostics (4 papers), Medical Imaging Techniques and Applications (3 papers), Breast Lesions and Carcinomas (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Cancer Research (150 citations), Oncology (218 citations) and Pulmonary and Respiratory Medicine (117 citations). Joan B. Heijns has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Hanneke W.M. van Laarhoven, Saskia van de Ven, Vincent T.H.B.M. Smit, Lonneke W. Kessels, Judith R. Kroep, Ernest J. T. Luiten, Birgit E. P. J. Vriens, Jolien Tol, Ayoub Charehbili and Manon J. Pepels. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, ESMO Open, Clinical Cancer Research and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact